← Back to all trials
Not Yet Recruiting
NCT07753356
VALIDATION OF FUSION CEMEP SCORE FOR OMITTING SYSTEMATIC PROSTATE BIOPSY
Conditions: Prostate Cancer, Prostatic Neoplasms/Diagnosis
Sex: Male
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 150
Sponsor: Marcelo Ruben Oliva
Location: Clinica Cemep Rio Grande Tierra del Fuego Province
Summary
This study aims to prospectively validate the Fusion CEMEP score to assess the safety and efficacy of omitting systematic prostate biopsy in patients undergoing multiparametric magnetic resonance imaging-targeted biopsy. The main objective is to determine if target-only biopsy guided by the score is sufficient for clinically significant prostate cancer detection while reducing overtreatment and unnecessary cores.
Eligibility Criteria
Inclusion Criteria:
* Adult male patients with clinical suspicion of prostate cancer.
* Patients scheduled to undergo multiparametric MRI-targeted prostate biopsy.
* Signed informed consent.
Exclusion Criteria:
* Prior treatment for prostate cancer.
* Contraindications to prostate biopsy or multiparametric MRI.
Source: ClinicalTrials.gov (NCT07753356). StuddyBuddy aggregates publicly available trial information.
